ランキング価格はじめての方へ
  1. 米国企業
  2. CASSAVA SCIENCES INC

CASSAVA SCIENCES INCSAVA

時価総額
$11.7億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Cash and cash equivalents73494941311710202394233201121
Cash and cash equivalents73494941311710202394233201121
Prepaid expenses and other current assets----------11108
Prepaid expenses and other current assets----------11108
Total current assets98575041321911202394244211130
Total current assets98575041321911202394244211130
Operating lease right-of-use assets--------0000-
Property and equipment, net0--0000000212322
Intangible assets, net----------110
Total assets99575041321911202394267235152
Accounts payable and other accrued expenses------------11
Accounts payable000010000174-
Accrued development expense------------3
Accrued development expense----10001132-
Accrued compensation and benefits1111100000200
Accrued compensation and benefits1111100000200
Operating lease liabilities, current--------0000-
Operating lease liabilities, current--------0000-
Other current liabilities--------00100
Other current liabilities--------00100
Total current liabilities13102131111213714
Total current liabilities13102131111213714
Operating lease liabilities, non-current---------000-
Operating lease liabilities, non-current---------000-
Other non-current liabilities----------00-
Other non-current liabilities----------00-
Total liabilities55442131111213714
Common stock, $0.001 par value; 120,000,000 shares authorized; 42,236,919 and 41,735,557 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively0000000000000
Common stock, $0.001 par value; 120,000,000 shares authorized; 41,735,557 and 40,016,792 shares issued and outstanding at December 31, 2022 and 2021, respectively0000000000000
Additional paid-in capital176149152157160164167184191267461511518
Additional paid-in capital176149152157160164167184191267461511518
Retained Earnings (Accumulated Deficit)-132-136-104-116-131-145-157-164-169-175-207-284-381
Retained Earnings (Accumulated Deficit)-132-136-104-116-131-145-157-164-169-175-207-284-381
Total stockholders' equity44134840291910202292254228137
Total stockholders' equity44134840291910202292254228137
Total liabilities and stockholders' equity99575041321911202394267235152
Cash and cash equivalents73494941311710202394233201121
Cash and cash equivalents73494941311710202394233201121
Prepaid expenses and other current assets----------11108
Prepaid expenses and other current assets----------11108
Total current assets98575041321911202394244211130
Total current assets98575041321911202394244211130
Operating lease right-of-use assets--------0000-
Property and equipment, net0--0000000212322
Intangible assets, net----------110
Total assets99575041321911202394267235152
Operating lease right-of-use assets--------0000-
Property and equipment, net0--0000000212322
Intangible assets, net----------110
Other assets00-00-00--0--
Total assets99575041321911202394267235152
Accounts payable and other accrued expenses------------11
Accounts payable000010000174-
Accrued development expense------------3
Accrued development expense----10001132-
Accrued compensation and benefits1111100000200
Accrued compensation and benefits1111100000200
Operating lease liabilities, current--------0000-
Operating lease liabilities, current--------0000-
Other current liabilities--------00100
Other current liabilities--------00100
Total current liabilities13102131111213714
Total current liabilities13102131111213714
Operating lease liabilities, non-current---------000-
Operating lease liabilities, non-current---------000-
Other non-current liabilities----------00-
Other non-current liabilities----------00-
Total liabilities55442131111213714
Total liabilities55442131111213714
Common stock, $0.001 par value; 120,000,000 shares authorized; 42,236,919 and 41,735,557 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively0000000000000
Common stock, $0.001 par value; 120,000,000 shares authorized; 41,735,557 and 40,016,792 shares issued and outstanding at December 31, 2022 and 2021, respectively0000000000000
Additional paid-in capital176149152157160164167184191267461511518
Additional paid-in capital176149152157160164167184191267461511518
Retained Earnings (Accumulated Deficit)-132-136-104-116-131-145-157-164-169-175-207-284-381
Retained Earnings (Accumulated Deficit)-132-136-104-116-131-145-157-164-169-175-207-284-381
Total stockholders' equity44134840291910202292254228137
Total stockholders' equity44134840291910202292254228137
Total liabilities and stockholders' equity99575041321911202394267235152
Total liabilities and stockholders' equity99575041321911202394267235152